New therapies for autoimmune myasthenia gravis

重症肌无力 医学 自身抗体 新生儿Fc受体 神经肌肉接头 抗体 阿格林 乙酰胆碱受体 神经肌肉传递 免疫学 受体 内科学 免疫球蛋白G 生物 神经科学
作者
Jan Verschuuren
出处
期刊:Lancet Neurology [Elsevier]
卷期号:22 (5): 368-369 被引量:1
标识
DOI:10.1016/s1474-4422(23)00125-4
摘要

Myasthenia gravis is a rare, chronic autoimmune disease of the neuromuscular junction that is characterised by muscle weakness. Most people with the disease have antibodies against one of the transmembrane proteins at the synapse, such as the acetylcholine receptor (AChR) or muscle-specific tyrosine kinase (MuSK). Activation of complement by AChR antibodies is thought to be one of the key pathogenic mechanisms for autoimmune myasthenia gravis. 1 Mantegazza R Bernasconi P Cavalcante P Myasthenia gravis: from autoantibodies to therapy. Curr Opin Neurol. 2018; 31: 517-525 Crossref PubMed Scopus (38) Google Scholar Complement inhibition—in particular of component 5 (C5)—prevents formation of the membrane attack complex, subsequently limiting the capacity of AChR antibodies to damage the postsynaptic muscle membrane, and helping the muscle to withstand the autoantibody attack. Another potential therapeutic target in autoimmune myasthenia gravis is the neonatal Fc receptor (FcRn), which plays a part in the transfer of maternal IgGs to neonates as well as trafficking IgGs and albumin into recycling pathways through vascular endothelial cells. 2 Roopenian DC Akilesh S FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol. 2007; 7: 715-725 Crossref PubMed Scopus (1644) Google Scholar Blocking of FcRn might reduce overall levels of IgG and pathogenic autoantibodies. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 studyRozanolixizumab showed clinically meaningful improvements in patient-reported and investigator-assessed outcomes in patients with generalised myasthenia gravis, for both 7 mg/kg and 10 mg/kg doses. Both doses were generally well tolerated. These findings support the mechanism of action of neonatal Fc receptor inhibition in generalised myasthenia gravis. Rozanolixizumab represents a potential additional treatment option for patients with generalised myasthenia gravis. Full-Text PDF Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 studyZilucoplan treatment showed rapid and clinically meaningful improvements in myasthenia gravis-specific efficacy outcomes, had a favourable safety profile, and was well tolerated, with no major safety findings. Zilucoplan is a new potential treatment option for a broad population of patients with AChR-positive generalised myasthenia gravis. The long-term safety and efficacy of zilucoplan is being assessed in an ongoing open-label extension study. Full-Text PDF Correction to Lancet Neurol 2023; 22: 368–69Verschuuren J. New therapies for autoimmune myasthenia gravis. Lancet Neurol 2023; 22: 368–69—In this Comment, the drug rozanolixizumab was misspelled twice. This correction has been made to the online version as of May 18, 2023. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
TTDY完成签到 ,获得积分10
4秒前
J陆lululu完成签到 ,获得积分10
5秒前
yuyu完成签到 ,获得积分10
7秒前
没用的三轮完成签到,获得积分10
8秒前
番茄小超人2号完成签到 ,获得积分10
9秒前
小马甲应助科研通管家采纳,获得10
10秒前
思源应助科研通管家采纳,获得10
10秒前
Singularity应助科研通管家采纳,获得10
10秒前
心想事成完成签到 ,获得积分10
12秒前
Diaory2023完成签到 ,获得积分10
13秒前
娇娇大王完成签到,获得积分10
14秒前
戈戈唔完成签到 ,获得积分10
25秒前
火箭Lucky完成签到 ,获得积分10
32秒前
平常向雪完成签到 ,获得积分10
38秒前
子非鱼完成签到 ,获得积分10
42秒前
感性的神级完成签到,获得积分10
43秒前
蓝绝完成签到 ,获得积分10
45秒前
digger2023完成签到 ,获得积分10
1分钟前
小竹完成签到 ,获得积分10
1分钟前
纷纭完成签到,获得积分10
1分钟前
ihonest完成签到,获得积分10
1分钟前
取法乎上完成签到 ,获得积分10
1分钟前
实力不允许完成签到 ,获得积分10
1分钟前
研友_8KXkJL完成签到 ,获得积分10
1分钟前
Aixia完成签到 ,获得积分10
1分钟前
LuciusHe完成签到,获得积分10
1分钟前
chichenglin完成签到 ,获得积分10
1分钟前
kais完成签到 ,获得积分10
1分钟前
谦让月饼完成签到 ,获得积分10
1分钟前
zmx完成签到 ,获得积分10
1分钟前
每天学习一点点完成签到 ,获得积分10
1分钟前
lyp完成签到 ,获得积分10
1分钟前
yugongjie完成签到 ,获得积分10
1分钟前
满意的雪枫完成签到 ,获得积分10
1分钟前
科研通AI2S应助李冲肖采纳,获得10
2分钟前
感动尔柳完成签到 ,获得积分20
2分钟前
isedu完成签到,获得积分10
2分钟前
LT完成签到 ,获得积分10
2分钟前
小二郎应助科研通管家采纳,获得10
2分钟前
勤恳的TT完成签到 ,获得积分10
2分钟前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052652
求助须知:如何正确求助?哪些是违规求助? 2709863
关于积分的说明 7418267
捐赠科研通 2354446
什么是DOI,文献DOI怎么找? 1246020
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595921